VOGLIZOME M 0.2
VOGLIZOME M combines Voglibose and Metformin, two antidiabetic medications used for the management of type 2 diabetes mellitus. Voglibose is an alpha-glucosidase inhibitor that delays the absorption of carbohydrates, helping to control postprandial blood glucose spikes. Metformin is a biguanide that works by decreasing glucose production in the liver and improving insulin sensitivity, thus lowering blood glucose levels. The combination of these two drugs provides a comprehensive approach to blood glucose management.
| SKU: | 002 |
| category: | vitamins |
| tags: | suppliments |
Composition
Each tablet contains:
| Voglibose: | 0.2 mg. |
| Metformin: | 500 mg |
Enhanced Glycemic Control: The combination of Voglibose and Metformin provides effective
control of both fasting and postprandial blood glucose levels.
Reduces Postprandial Glucose Spikes: Voglibose helps prevent after-meal glucose spikes by
delaying carbohydrate absorption.
Decreases Hepatic Glucose Production: Metformin lowers blood glucose levels by reducing
glucose production in the liver and improving insulin sensitivity.
Improves Insulin Sensitivity: Metformin enhances the body’s response to insulin, which helps in
better management of blood glucose.
Low Risk of Hypoglycemia: This combination has a lower risk of causing hypoglycemia
compared to some other diabetes medications.
Diarrhea
Liver enzyme abnormalities
Stomach cramps
Hypoglycemia (low blood sugar when combined with other antidiabetics)